Literature DB >> 15067341

Establishment and characterization of unique human gallbladder cancer cell lines.

Mila Ghosh1, Naoto Koike, Go Yanagimoto, Shin-Ichi Tsunoda, Sunil Kaul, Takashi Hirano, Fabian Emura, Hironobu Kashiwagi, Toru Kawamoto, Nobuhiro Ohkohchi, Kaoru Saijo, Tadao Ohno, Masanao Miwa, Takeshi Todoroki.   

Abstract

Gallbladder cancer has a dismal prognosis. Understanding the disease at the biological, genetic, molecular, cellular, and clinical level is essential for effective diagnostics and therapeutics. However, the currently established gallbladder cell lines are insufficient for better understanding and further research. The aim of our present study was to establish and characterize human gallbladder cancer cell lines. We established 5 cell lines from resected specimens of gallbladder cancers. These cell lines revealed typical tumor histopathological characteristics. We examined growth characteristics and the colony-forming ability of established cell lines in terms of their cell cycle parameters, expression of tumor markers (carcinoembryonic antigen; CEA, carbohydrated antigen 19-9; CA19-9, MUC-1 and c-kit) and the oncogene c-erbB2 by flow cytometer. Comparative genomic hybridization (CGH) analysis with specific gene probes was performed to detect changes in the gene copy numbers. Human origin of cell lines was confirmed by chromosomal analysis. Cells maintained differentiation characteristics of the original tumors. The doubling time of different cell lines varied from 30 to 96 h. All 5 cell lines formed colonies in the colony forming assays and expressed CEA, CA19-9, MUC-1 and the oncogene c-erbB2 and showed chromosomal aneuploidy. CGH analysis demonstrated gain of chromosomal region bearing SRC, RAB1, and PAP in all cell lines and hTERT in 4 cell lines. These newly established cell lines might serve as a useful model for studying the molecular pathogenesis of gallbladder cancer. Furthermore, they may serve as a model for testing new therapeutics against gallbladder cancer. These chromosomal aberrations and imbalances provide a starting point for molecular analyses of genomic regions and genes in gallbladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067341

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Establishment and characterization of HEPFT, a cell line derived from hepatoid carcinoma of the fallopian tube, with special reference to alpha-fetoprotein, lectin affinity and histogenesis.

Authors:  Iwao Ishiwata; Makoto Yasuda; Takashi Hirano; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2007-11       Impact factor: 4.174

2.  Frequent activation of mitogen-activated protein kinase relative to Akt in extrahepatic biliary tract cancer.

Authors:  Hiroshige Hori; Tetsuo Ajiki; Yoshiyasu Mita; Hideki Horiuchi; Kenro Hirata; Taku Matsumoto; Haruki Morimoto; Tsunenori Fujita; Yonson Ku; Yoshikazu Kuroda
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

3.  Establishment of a human malignant fibrous mesothelioma cell line and the biological characteristics compared with malignant epithelial mesothelioma cell line.

Authors:  Iwao Ishiwata; Emiko Ishiwata; Takashi Hirano
Journal:  Hum Cell       Date:  2008-08       Impact factor: 4.174

4.  AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines.

Authors:  Pamela Leal; Patricia Garcia; Alejandra Sandoval; Kurt Buchegger; Helga Weber; Oscar Tapia; Juan C Roa
Journal:  Onco Targets Ther       Date:  2013-10-03       Impact factor: 4.147

5.  Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.

Authors:  Patricia García; Carolina Bizama; Lorena Rosa; Jaime A Espinoza; Helga Weber; Javier Cerda-Infante; Marianela Sánchez; Viviana P Montecinos; Justo Lorenzo-Bermejo; Felix Boekstegers; Marcela Dávila-López; Francisca Alfaro; Claudia Leiva-Acevedo; Zasha Parra; Diego Romero; Sumie Kato; Pamela Leal; Marcela Lagos; Juan Carlos Roa
Journal:  Biol Res       Date:  2020-04-15       Impact factor: 5.612

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.